Health Care • Medical/Dental Instruments
$61.25 ▼ -1.23
(-1.97%)
MKT CAP: $3.18B • VOL: 967.4K
52W L $25 52W H $63
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$51
MEDIAN
$69
MEAN
$70
HIGH
$83
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ATRC TAPE
ATRC // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $74.11 | $70.44 | 2025-02-14 | $55.74 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $77.17 | $72.27 | 2025-02-06 | $57.57 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $69.82 | $67.38 | 2025-01-29 | $58.80 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $62.48 | — | 2025-01-17 | $60.02 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $53.90 | $58.19 | 2025-01-09 | $54.51 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $72.89 | $63.70 | 2024-12-18 | $53.29 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $59.41 | $61.86 | 2024-12-04 | $56.96 | -4.3% | 48% | C |